IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
According to the Fertility Society of Australia, one in six Australian couples face infertility issues. The Fertility Clinics industry assists patients who are having difficulty with or an inability to conceive naturally. The industry offers numerous treatment options, the most popular being in IVF cycles. Several factors have driven demand for fertility treatments and procedures in recent years, as Australian women are having children later in life. Australia is one of the few economically advanced countries in the world that has significant government funding for fertility treatments, which makes fertility treatments more affordable. One in eighteen babies born in Australia is born with IVF, highlighting the scale of the industry.
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Fertility Clinics industry in Australia includes market sizing, forecasting, data and analysis from 2016-2031. The most recent publication was released March 2026.
The Fertility Clinics industry in Australia operates under the ANZSIC industry code OD5091. Medical facilities in the industry offer treatments to aid individuals in conceiving children. These facilities offer diagnosis, medications, intrauterine insemination and other assisted reproductive technology (ART) methods. This includes core ART treatments such as in-vitro fertilisation (IVF) cycles and frozen embryo transfers, in addition to associated ancillary health services such as specialised diagnostic and genetic testing, ultrasounds and related day hospital procedures. Related terms covered in the Fertility Clinics industry in Australia include in-vitro fertilisation (ivf), cytogenetics, ovulation induction, intra-uterine insemination (iui), assisted reproductive treatment (art) and frozen embryo transfer (fet).
Products and services covered in Fertility Clinics industry in Australia include In-vitro fertilisation, Frozen embryo transfer and Intrauterine insemination.
Companies covered in the Fertility Clinics industry in Australia include Virtus Health, Monash IVF and Genea.
The Performance chapter covers detailed analysis, datasets, detailed current performance, sources of volatility and an outlook with forecasts for the Fertility Clinics industry in Australia.
Questions answered in this chapter include what's driving current industry performance, what influences industry volatility, how do successful businesses overcome volatility, what's driving the industry outlook. This analysis is supported with data and statistics on industry revenues, costs, profits, businesses and employees.
The Products and Markets chapter covers detailed products and service segmentation and analysis of major markets for the for the Fertility Clinics industry in Australia.
Questions answered in this chapter include how are the industry's products and services performing, what are innovations in industry products and services, what products or services do successful businesses offer and what's influencing demand from the industry's markets. This includes data and statistics on industry revenues by product and service segmentation and major markets.
The Geographic Breakdown chapter covers detailed analysis and datasets on regional performance of the Fertility Clinics industry in Australia.
Questions answered in this chapter include where are industry businesses located and how do businesses use location to their advantage. This includes data and statistics on industry revenues by location.
The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Fertility Clinics industry in Australia. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.
Questions answered in this chapter include what impacts the industry's market share concentration, how do successful businesses handle concentration, what challenges do potential industry entrants face, how can potential entrants overcome barriers to entry, what are substitutes for industry services, how do successful businesses compete with substitutes and what power do buyers and suppliers have over the industry and how do successful businesses manage buyer & supplier power.
The Companies chapter covers Key Takeaways, Market Share and Companies in the Fertility Clinics industry in Australia. This includes data and analysis on companies operating in the industry that hold a market share greater than 5%.
Questions answered in this chapter include what companies have a meaningful market share and how each company is performing.
The External Environment chapter covers Key Takeaways, External Drivers, Regulation & Policy and Assistance in the Fertility Clinics industry in Australia. This includes data and statistics on factors impacting industry revenue such as economic indicators, regulation, policy and assistance programs.
Questions answered in this chapter include what demographic and macroeconomic factors impact the industry, what regulations impact the industry, what assistance is available to this industry.
The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Fertility Clinics industry in Australia. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.
Questions answered in this chapter include what trends impact industry costs and how financial ratios have changed overtime.
The Industry Data chapter includes 10 years of historical data with 5 years of forecast data covering statistics like revenue, industry value add, establishments, enterprises, employment and wages in the Fertility Clinics industry in Australia.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
The market size of the Fertility Clinics industry in Australia is $893.9m in 2026.
There are 40 businesses in the Fertility Clinics industry in Australia, which has grown at a CAGR of 1.6 % between 2021 and 2026.
The Fertility Clinics industry in Australia is unlikely to be materially impacted by import tariffs with imports accounting for a low share of industry revenue.
The Fertility Clinics industry in Australia is unlikely to be materially impacted by export tariffs with exports accounting for a low share of industry revenue.
The market size of the Fertility Clinics industry in Australia has been growing at a CAGR of 1.7 % between 2021 and 2026.
Over the next five years, the Fertility Clinics industry in Australia is expected to grow.
The biggest companies operating in the Fertility Clinics industry in Australia are Virtus Health, Monash IVF and Genea
Intracytoplasmic sperm injection and Intrauterine insemination are part of the Fertility Clinics industry in Australia.
The company holding the most market share in the Fertility Clinics industry in Australia is Virtus Health.
The level of competition is low and increasing in the Fertility Clinics industry in Australia.